
HARTFORD, CT — Without any guarantees from Washington, Connecticut’s insurance regulators decided to allow two carriers to boost their premiums for plans on the individual market in 2018 by an average of 31.7 percent for Anthem and 27.7 percent for ConnectiCare Benefit customers.
The increases approved assume that Cost Sharing Reduction (CSR) payments — which go to insurance companies to offset deductibles and co-insurance for lower income individuals — won’t continue.
Insurance Department officials said that if there was a guarantee that the CSRs would continue, the approved rate increase for ConnectiCare Benefits would have been 16.8 percent, instead of 27.7 percent, and for Anthem Health Plans it would have been 24.7 percent, instead of 31.7 percent.
“The Department has made its rate determinations for 2018 to provide certainty for Connecticut consumers, the insurance market and Access Health CT to be ready for the individual market open enrollment period which begins November 1, 2017,” Insurance Commissioner Katharine Wade said. “The increase in rates for the Silver exchange plans will be mitigated for consumers, eligible for federal tax credits, because they will be offset by the increase to tax credits for 2018.”
The federal tax credits will increase for customers who would have traditionally been subsidized through CSRs.
The two insurance carriers received about $50 million a year in CSRs for 46,000 of the 98,000 exchange customers. About 25 percent of the 98,000 exchange customers receive advanced premium tax credits and 25 percent receive no financial assistance.
Insurance regulators determined that medical costs increased an average of 10.5 percent and the elimination of the moratorium on the health insurance tax increased premiums an average of 3 percent. The average increases assumed for the elimination of the CSR payments was 16.7 percent, and it’s applied only to the silver plans on the exchange.
“This has been a challenging year for all involved due to the uncertainty about federal funding for the Cost Sharing Reductions (CSR) payments and individual market stability challenges. CSR payments are important financial relief for consumer out-of-pocket costs,” Wade said. “We continue to work with the Malloy administration, our congressional delegation and fellow insurance regulators on solutions that will provide certainty on CSR funding and stabilize the market for our citizens.”
Connecticut officials, including Wade and Access Health CT CEO James Wadleigh, have reached out to members of Congress to make suggestions about what can be done to stabilize the individual marketplaces.
The federal government could guarantee the CSRs, enforce the penalty people are supposed to pay if they choose not to purchase insurance, or create a “national reinsurance pool,” Wadleigh has said.
Support authentic, locally owned and operated public service journalism!
At the end of September, Republicans will no longer be able to pass a repeal bill in the U.S. Senate with 50 votes. U.S. Sen. Chris Murphy speculated earlier this week that they will try once more to repeal the Affordable Care Act, also known as Obamacare, but those attempts will be made harder by the progress the Senate Health, Education, Labor and Pensions Committee is making on a bipartisan package of reforms and fixes.
Murphy said the goal within the several days is to come up with a small package of reforms that can pass the Senate and send a message of stability to the insurance markets.
Gov. Dannel P. Malloy and Lt. Gov. Nancy Wyman announced earlier today that the two insurance companies had decided to participate in 2018.
More Health Care News & Analysis

6 Common Barriers Men Face When Seeking Mental Health Support
The outward effects of mental illness can often be dismissed as a sign of weakness or personal failure. For men, this type of social stereotyping can be especially hard to escape — being told to “man up” is a common refrain that can be reductive and stigmatizing.
Keep readingMedical Examining Board Fines Doctor $10,000
The state Medical Examining Board on Tuesday fined an Oxford doctor $10,000 for fraudulently using another doctor’s name and Drug Enforcement Agency registration number to prescribe controlled substances to a family member.
Keep reading
Clinical Trials With Immunotherapy Drugs Are Source Of Hope And Challenges In Treating Aggressive Breast Cancer
Joshalyn Mills of Branford and Nancy Witz of Kensington had the best possible results after being treated in clinical trials with immunotherapy drugs for aggressive breast cancer: Their tumors were eliminated. But while there are dramatic successes with immunotherapy drugs, there are also many failures, and researchers are trying to find out why in hopes…
Keep reading
Coalition of Health Insurers Questions Viability of Connecticut Partnership Plan
Members of Connecticut’s Health Care Future, a coalition of health insurers, hospitals, and businesses, are questioning whether Connecticut lawmakers have done enough this year to protect teachers and municipal employees from increases in health insurance premiums. “Despite repeated bailouts from taxpayers, the Connecticut Partnership Plan continues to be a fiscal Titanic that demonstrates why government-controlled health…
Keep reading
AG’s Tackle Mental Health Parity
Attorneys General in Connecticut and Rhode Island threw their support Monday behind a coalition of mental health advocacy groups asking a federal appeals court to revisit a recent ruling giving insurance companies more flexibility to deny mental health claims.
Keep reading
Budget Green Lights Psychedelic Therapies
Buried in the budget Gov. Ned Lamont signed this week is a provision that would create a pilot program to allow Connecticut to be the first-in-the-nation to study the impact of psychedelic drugs like psilocybin and MDMA on patients with depression and PTSD. The budget now creates a pilot program within the Department of Mental…
Keep reading